Detalhe da pesquisa
1.
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
BMC Med Res Methodol
; 22(1): 155, 2022 05 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35637426
2.
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria.
Rev Neurol (Paris)
; 178(10): 1098-1104, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36180289
3.
[Prognostics factors of renal failure in multiple sclerosis]. / Facteurs pronostiques d'urétéro-hydronéphrose (UHN) chez les patients atteints de sclérose en plaques (SEP).
Prog Urol
; 22(16): 1026-32, 2012 Dec.
Artigo
Francês
| MEDLINE | ID: mdl-23178100
4.
[Acute upper limb ischemia in a young adult without cardiac disease. Value of transesophageal echocardiography]. / Ischémie aiguë des membres supérieurs chez une adulte jeune sans cardiopathie. Intérêt de l'échographie transoesophagienne.
Arch Mal Coeur Vaiss
; 89(10): 1317-21, 1996 Oct.
Artigo
Francês
| MEDLINE | ID: mdl-8952832
5.
[Infectious myelopathies: clinical, serological, and prognostic patterns]. / Myélopathies infectieuses: profils cliniques, paracliniques et évolutifs.
Rev Neurol (Paris)
; 160(11): 1048-58, 2004 Nov.
Artigo
Francês
| MEDLINE | ID: mdl-15602347
6.
Teaching NeuroImages: marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion.
Neurology
; 74(20): e87, 2010 May 18.
Artigo
Inglês
| MEDLINE | ID: mdl-20479354
7.
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 76(12): 1624-9, 2005 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-16291883